These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 20091460)

  • 1. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
    Chang YC; Chang TJ; Lee WJ; Chuang LM
    Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl-peptidase 4 and attractin expression is increased in circulating blood monocytes of obese human subjects.
    Laudes M; Oberhauser F; Schulte DM; Schilbach K; Freude S; Bilkovski R; Schulz O; Faust M; Krone W
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):473-7. PubMed ID: 20198559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.
    Moschen AR; Molnar C; Wolf AM; Weiss H; Graziadei I; Kaser S; Ebenbichler CF; Stadlmann S; Moser PL; Tilg H
    J Hepatol; 2009 Oct; 51(4):765-77. PubMed ID: 19664840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease.
    Moschen AR; Geiger S; Gerner R; Tilg H
    Mutat Res; 2010 Aug; 690(1-2):95-101. PubMed ID: 19583971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
    Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
    Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine.
    Sommer G; Garten A; Petzold S; Beck-Sickinger AG; Blüher M; Stumvoll M; Fasshauer M
    Clin Sci (Lond); 2008 Jul; 115(1):13-23. PubMed ID: 19016657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nampt and its potential role in inflammation and type 2 diabetes.
    Garten A; Petzold S; Schuster S; Körner A; Kratzsch J; Kiess W
    Handb Exp Pharmacol; 2011; (203):147-64. PubMed ID: 21484571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study.
    Retnakaran R; Youn BS; Liu Y; Hanley AJ; Lee NS; Park JW; Song ES; Vu V; Kim W; Tungtrongchitr R; Havel PJ; Swarbrick MM; Shaw C; Sweeney G
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):885-93. PubMed ID: 18410550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats.
    Sun Q; Li L; Li R; Yang M; Liu H; Nowicki MJ; Zong H; Xu J; Yang G
    Ann Med; 2009; 41(4):311-20. PubMed ID: 19263259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women.
    Unlütürk U; Harmanci A; Yildiz BO; Bayraktar M
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):469-74. PubMed ID: 19650786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum resistin levels in Syrian obese patients with diabetes mellitus type II.
    Al-Sari IE; Al-Quobaili FA; Kabalan YM
    Saudi Med J; 2007 Dec; 28(12):1890-4. PubMed ID: 18060223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visfatin expression is elevated in normal human pregnancy.
    Morgan SA; Bringolf JB; Seidel ER
    Peptides; 2008 Aug; 29(8):1382-9. PubMed ID: 18524416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visfatin, low-grade inflammation and body mass index (BMI).
    Samara A; Pfister M; Marie B; Visvikis-Siest S
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):568-74. PubMed ID: 18248642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visfatin -948G/T and resistin -420C/G polymorphisms in Egyptian type 2 diabetic patients with and without cardiovascular diseases.
    Motawi TM; Shaker OG; El-Sawalhi MM; Abdel-Nasser ZM
    Genome; 2014 May; 57(5):259-66. PubMed ID: 25120107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals.
    Mabrouk R; Ghareeb H; Shehab A; Omar K; El-Kabarity RH; Soliman DA; Mohamed NA
    Egypt J Immunol; 2013; 20(1):1-11. PubMed ID: 23888552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes.
    Garten A; Petzold S; Barnikol-Oettler A; Körner A; Thasler WE; Kratzsch J; Kiess W; Gebhardt R
    Biochem Biophys Res Commun; 2010 Jan; 391(1):376-81. PubMed ID: 19912992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.